Olema Pharmaceuticals (OLMA) Current Assets (2020 - 2026)

Olema Pharmaceuticals (OLMA) has reported Current Assets for 7 consecutive years, with $513.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Assets rose 29.39% year-over-year to $513.2 million; the TTM figure through Mar 2026 stood at $513.2 million (up 29.39% YoY), while the FY2025 annual figure was $515.5 million, up 17.56% from the prior year.
• Current Assets steadied at $513.2 million in Q1 2026 per OLMA's latest filing, from $515.5 million in the prior quarter.
• Across five years, Current Assets topped out at $515.5 million in Q4 2025 and bottomed at $171.5 million in Q2 2023.
• Historically, Current Assets has averaged $302.0 million across 5 years, with a median of $266.5 million in 2023.
• Annual changes were most pronounced in 2023 — Current Assets decreased 29.91% — and 2024, when it jumped 64.52%.
• Olema Pharmaceuticals' Current Assets stood at $208.9 million in 2022, then rose by 27.58% to $266.5 million in 2023, then surged by 64.52% to $438.5 million in 2024, then gained by 17.56% to $515.5 million in 2025, then slipped by 0.43% to $513.2 million in 2026.
• Business Quant data shows OLMA's Current Assets at $513.2 million in Q1 2026, $515.5 million in Q4 2025, and $334.3 million in Q3 2025.